MetLife Investment Advisors »

Century Therapeutics shares owned by MetLife Investment Advisors

Quarter-by-quarter ownership of Century Therapeutics (IPSC) shares owned by MetLife Investment Advisors from 13F filings

Historical chart of MetLife Investment Advisors investment in Century Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Century Therapeutics held by MetLife Investment Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Century Therapeutics by MetLife Investment Advisors

Quarter filed Position value Share count Share price at filing
2026-06-30 $187k 76k 2.45
2022-12-31 $62k 12k 5.13
2022-09-30 $120k 12k 9.86
2022-06-30 $102k 12k 8.38
2022-03-31 $153k 12k 12.58
2021-09-30 $124k 4.9k 25.16